Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Feb 7, 2019; 25(5): 622-631
Published online Feb 7, 2019. doi: 10.3748/wjg.v25.i5.622
Table 1 Parameters of diffusion-weighted imaging, T1-weighted imaging, T2-weighted imaging, and VIBE sequence
ParameterDWIIn/out of phase
T2-weighted imagingVIBE
T1-weighted imaging
Repetition time (ms)56008121603.95
Echo time (ms)681.41001.92
Field of view (mm2)380 × 289400 × 325433 × 433400 × 296
Scan matrix100 × 76352 × 286320 × 20288352 × 256
Slice thickness (mm)6662
Slice gap (mm)12.72.70
Number of excitation121
Table 2 Patients’ baseline characteristics
CharacteristicValue
Clinical information
Age (yr)50.31 ± 10.87 (range: 26-77)
Male/female157/46
Etiology of liver disease
Hepatitis B virus194 (95.57%)
Hepatitis C virus8 (3.94%)
Both hepatitis B and C virus1 (0.49%)
Tumor size (cm)Median 5.3 (range: 1.1-12.8)
AFP level (ng/mL)102.3 ng/mL (range 1.2-15926.0)
Serum AST (≥ 35 IU/L)107 (52.7%)
Serum ALT (≥ 40 IU/L)82 (40.4%)
Table 3 Sensitivity, specificity, and accuracy of the liver imaging reporting and data system category for diagnosing hepatocellular carcinoma with gadoxetic-acid enhanced magnetic resonance imaging
GroupDWISensitivity (100%)Specificity (100%)Accuracy (100%)PPV (100%)NPV (100%)Youden index
LR-5A-DWI61.2 (101/165)92.5 (74/80)71.4 (175/245)94.4 (101/107)53.6 (74/138)0.537
P-DWI61.2 (101/165)92.5 (74/80)71.4 (175/245)94.4 (101/107)53.6 (74/138)0.537
LR-4/5A-DWI73.9 (122/165)80 (64/80)75.9 (186/245)88.4(122/138)59.8 (64/107)0.539
P-DWI87.9 (145/165)80 (64/80)85.3 (209/245)90.1 (145/161)76.2 (64/84)0.679
LR-4/5/MA-DWI75.8 (125/165)58.8 (47/80)70.2 (172/245)79.1 (125/158)54 (47/87)0.346
P-DWI87.9 (145/165)58.8 (47/80)78.4 (192/245)81.5 (145/178)70.1 (47/67)0.467
LR-4/5/TIVA-DWI75.8 (125/165)75 (60/80)75.5 (185/245)86.2 (125/145)60 (60/100)0.508
P-DWI89.7 (148/165)75 (60/80)84.9 (208/245)88.1 (148/168)77.9 (60/77)0.647